QMS
From GWAVA Technologies Training
Revision as of 07:46, 22 October 2014 by 37.187.144.114 (Talk)
Other amount <a href=" http://www.symptotherm.ch/liens-externes ">silagra 50</a> LONDON, Sept 20 (Reuters) - An experimental drug forDuchenne muscular dystrophy (DMD) from GlaxoSmithKline and Prosensa failed to meet its goal in a late-stageclinical trial, sending shares in Prosensa tumbling 70 percent.
